Show simple item record

dc.relation.isnodouble5192*
dc.contributor.authorDe Silva, Prathiba
dc.contributor.authorMahmud, Ayesha
dc.contributor.authorSmith, Paul P.
dc.contributor.authorClark, Thomas J.
dc.date.accessioned2023-07-12T13:28:52Z
dc.date.available2023-07-12T13:28:52Z
dc.date.issued2020-07
dc.identifier.citationDe Silva PM, Mahmud A, Smith PP, Clark TJ. Analgesia for Office Hysteroscopy: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2020 Jul-Aug;27(5):1034-1047.en_US
dc.identifier.issn1553-4650
dc.identifier.eissn1553-4669
dc.identifier.doi10.1016/j.jmig.2020.01.008
dc.identifier.pmid31982584
dc.identifier.urihttp://hdl.handle.net/20.500.14200/1225
dc.description.abstractObjective: To identify the most effective analgesia for women undergoing office hysteroscopy. Data sources: We searched Medline, Embase, the Cumulative Index to Nursing and Allied Health Literature, and the Cochrane Library from inception until August 2019 for studies that investigated the effect of different analgesics on pain control in office hysteroscopy. Methods of study selection: We included randomized controlled trials that investigated the effect of analgesics on pain experienced by women undergoing diagnostic or operative hysteroscopy in an office setting compared with the control group. Tabulation, integration, and results: The literature search returned 561 records. Twenty-two studies were selected for a systematic review, of which 16 were suitable for meta-analysis. There was a statistically significant reduction in pain during office hysteroscopy associated with preprocedural administration of nonsteroidal anti-inflammatory drugs (NSAIDs) (standardized mean difference [SMD] -0.72; 95% confidence interval [CI] -1.27 to -0.16), opioids (SMD -0.50; 95% CI -0.97 to -0.03), and antispasmodics (SMD -1.48; 95% CI -1.82 to -1.13), as well as with the use of transcutaneous electrical nerve stimulation (TENS) (SMD -0.99; 95% CI -1.67 to -0.31), compared with the control group. Moreover, similar reduction in pain was observed after office hysteroscopy: NSAIDs (SMD -0.55; 95% CI -0.97 to -0.13), opioids (SMD -0.73; 95% CI -1.07 to -0.39), antispasmodics (SMD -1.02; 95% CI -1.34 to -0.69), and TENS (SMD -0.54; 95% CI -0.95 to -0.12). Significantly reduced pain scores with oral NSAID administration during (SMD -0.87; 95% CI -1.59 to -0.15) and after (SMD -0.56; 95% CI -1.02 to -0.10) office hysteroscopy were seen in contrast to other routes. Significantly more adverse effects were reported with the use of opioids (p <.001) and antispasmodics (p <.001) when compared with the control group, in contrast to NSAIDs (p = .97) and TENS (p = .63). Conclusion: Women without contraindications should be advised to take oral NSAIDs before undergoing office hysteroscopy to reduce pain during and after the procedure. TENS should be considered as an alternative analgesic in women with contraindications to NSAIDs.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectGynaecologyen_US
dc.titleAnalgesia for office hysteroscopy : a systematic review and meta-analysisen_US
dc.typeArticle
dc.source.journaltitleJournal of Minimally Invasive Gynecology
rioxxterms.versionNAen_US
dc.contributor.trustauthorMahmud, Ayesha
dc.contributor.departmentObstetrics and Gynaecologyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationUniversity of Birmingham; Walsall Healthcare NHS Trust; Birmingham Women's and Children's NHS Foundation Trusten_US
oa.grant.openaccessnaen_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record